Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Case 1. Cardiovascular dysfunction syndrome.

L A Leiter1

  • 1University of Toronto, and Lipid Clinic, St Michael's Hospital, Toronto, Canada.

The Canadian Journal of Cardiology
|July 25, 2000
PubMed
Summary

A 56-year-old woman with angina has cardiovascular dysmetabolic syndrome, increasing her risk for adverse cardiovascular events. This case highlights sequential management strategies and presents two opinions for further patient care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A systematic review and meta-analysis of randomized trials of substituting soymilk for cow's milk and intermediate cardiometabolic outcomes: understanding the impact of dairy alternatives in the transition to plant-based diets on cardiometabolic health.

BMC medicine·2024
Same author

Alirocumab efficacy and safety by body mass index: A pooled analysis from 10 Phase 3 ODYSSEY trials.

Diabetes & metabolism·2019
Same author

Glycaemic target attainment in people with Type 2 diabetes treated with insulin glargine/lixisenatide fixed-ratio combination: a post hoc analysis of the LixiLan-O and LixiLan-L trials.

Diabetic medicine : a journal of the British Diabetic Association·2019
Same author

Alirocumab safety in people with and without diabetes mellitus: pooled data from 14 ODYSSEY trials.

Diabetic medicine : a journal of the British Diabetic Association·2018
Same author

Efficacy and safety of alirocumab in people with prediabetes vs those with normoglycaemia at baseline: a pooled analysis of 10 phase III ODYSSEY clinical trials.

Diabetic medicine : a journal of the British Diabetic Association·2017
Same author

Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM-INSULIN trial.

Diabetes & metabolism·2017

Area of Science:

  • Cardiology
  • Metabolic Syndrome Research

Background:

  • A 56-year-old female patient presented with symptoms of angina.
  • Previous sequential management strategies yielded varied outcomes.

Observation:

  • The patient exhibits cardiovascular dysmetabolic syndrome.
  • This condition places her at a high risk for adverse cardiovascular events.

Findings:

  • The case underscores the complexity of managing patients with both angina and metabolic syndrome.
  • Sequential treatment approaches require careful consideration of individual patient risk factors.

Implications:

  • Effective management of cardiovascular dysmetabolic syndrome is crucial for preventing major adverse cardiovascular events.
  • Presenting differing clinical opinions aids in optimizing patient-specific treatment pathways.

Related Experiment Videos